GluN2A and GluN2B N-Methyl-D-Aspartate Receptor (NMDARs) Subunits: Their Roles and Therapeutic Antagonists in Neurological Diseases
Pharmaceuticals · 30.10.2023 · 16 (11) · 1535
DOI: 10.3390/ph16111535 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 30.10.2023. Verfasst von Amany Digal Ladagu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Veterinary Anatomy, University of Ibadan, Ibadan 200284, Nigeria. Die Arbeit wurde bisher 56-mal zitiert (Crossref) und nennt 181 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
N-methyl-D-aspartate receptors (NMDARs) are ion channels that respond to the neurotransmitter glutamate, playing a crucial role in the permeability of calcium ions and excitatory neurotransmission in the central nervous system (CNS). Composed of various subunits, NMDARs are predominantly formed by two obligatory GluN1 subunits (with eight splice variants) along with regulatory subunits GluN2 (GluN2A-2D) and GluN3 (GluN3A-B). They are widely distributed throughout the CNS and are involved in essential functions such as synaptic transmission, learning, memory, plasticity, and excitotoxicity. The presence of GluN2A and GluN2B subunits is particularly important for cognitive processes and has been strongly implicated in neurodegenerative diseases like Parkinson’s disease and Alzheimer’s disease. Understanding the roles of GluN2A and GluN2B NMDARs in neuropathologies provides valuable insights into the underlying causes and complexities of major nervous system disorders. This knowledge is vital for the development of selective antagonists targeting GluN2A and GluN2B subunits using pharmacological and molecular methods. Such antagonists represent a promising class of NMDA receptor inhibitors that have the potential to be developed into neuroprotective drugs with optimal therapeutic profiles.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Veterinary Anatomy, University of Ibadan, Ibadan 200284, Nigeria.
- Developmental Neurobiology Laboratory, Department of Anatomy, College of Medicine, University of Ibadan, Ibadan 200284, Nigeria.
- Department of Pharmaceutical Sciences, Philadelphia College of Pharmacy, Saint Joseph's University, Philadelphia, PA 19131, USA.
Zitieren
APA
Ladagu, A. D., Olopade, F. E., Adejare, A., & Olopade, J. O. (2023). GluN2A and GluN2B N-Methyl-D-Aspartate Receptor (NMDARs) Subunits: Their Roles and Therapeutic Antagonists in Neurological Diseases. Pharmaceuticals, 16(11), 1535. https://doi.org/10.3390/ph16111535
Vancouver
Ladagu AD, Olopade FE, Adejare A, Olopade JO. GluN2A and GluN2B N-Methyl-D-Aspartate Receptor (NMDARs) Subunits: Their Roles and Therapeutic Antagonists in Neurological Diseases. Pharmaceuticals. 2023;16(11):1535. doi:10.3390/ph16111535
BibTeX
@article{Ladagu2023,
author = {Ladagu, Amany Digal and Olopade, Funmilayo Eniola and Adejare, Adeboye and Olopade, James Olukayode},
title = {GluN2A and GluN2B N-Methyl-D-Aspartate Receptor (NMDARs) Subunits: Their Roles and Therapeutic Antagonists in Neurological Diseases},
journal = {Pharmaceuticals},
year = {2023},
volume = {16},
number = {11},
pages = {1535},
doi = {10.3390/ph16111535}
}
EUVIMED